Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib as adjuvant treatment for hepatocellular carcinoma after resection or local ablation
2008-001087-36Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Bayer. Started Jun 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2008-001087-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001087-36.